Table 1.
Selected outcomes reported in the two datasets; all adverse event (AE) cases considered per cohort. Note that the outcomes associated to a single event may be more than one.
Outcome | % Zevalin AEs | % Bexxar AEs | ||
---|---|---|---|---|
FAERS | VigiBase | FAERS | VigiBase | |
Death | 33.4 | 22.8 | 22.1 | 24.1 |
Hospitalization | 41.5 | 22.1 | 31.0 | 20.5 |
Life threatening | 7.4 | 3.9 | 7.9 | 5.2 |
Other | 46.3 | 31.8 | 36.6 | 23.1 |